Manglovo Health is developing ZAYA, a 1x/week, oral contraceptive without hormones- increasing convenience & mitigating side effects for the 151M global users of daily hormonal contraceptive pills. Our innovation optimizes ormeloxifene, a clinically validated drug used by millions in India, for on-patent international market entry with an improved long-term safety profile. With renowned expertise in women's health, medicinal chemistry, and drug development, our mission is to eliminate compromise in contraception and meet the growing market demand for hormone-free options.